FOXP4-AS1: A Potential Drug Target and Biomarker (G101060264)

Target Name: FOXP4-AS1

NCBI ID: G101060264

FOXP4-AS1

Other Name(s): FOXP4 antisense RNA 1 | FOXP4 antisense RNA 1, transcript variant 1

FOXP4-AS1: A Potential Drug Target and Biomarker

FOXP4-AS1, also known as ALDH1129077e, is a gene that encodes a protein known as FoxO4, a transcription factor that plays a crucial role in cell development, proliferation, and survival. The FoxO4 gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, targetingFOXP4-AS1 has been identified as a potential new drug target.

FOXP4-AS1 is a highly conserved gene that is expressed in a wide range of tissues and cells. It is highly expressed in the brain, and its expression has been linked to the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and neuroblastoma. In addition,FOXP4-AS1 has also been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer.

The role ofFOXP4-AS1 in cancer development and progression is not well understood, but it is thought to play a negative role.FOXP4-AS1 has been shown to promote the growth and survival of cancer cells, and it has also been shown to inhibit the production of anti-cancer drugs. As a result, targetingFOXP4-AS1 has been identified as a potential new drug target for cancer treatment.

In addition to its role in cancer, FOXP4-AS1 has also been implicated in the development and progression of neurodegenerative diseases. neurodegenerative diseases are a group of disorders that are characterized by the progressive loss of brain cells and their associated symptoms. These disorders include Alzheimer's disease, Parkinson's disease, and Huntington's disease.

The role ofFOXP4-AS1 in neurodegenerative diseases is not well understood, but it is thought to play a negative role.FOXP4-AS1 has been shown to promote the growth and survival of neurodegenerative disease-associated cells, and it has also been shown to inhibit the production of anti-neurodegenerative disease drugs. As a result, targetingFOXP4-AS1 has been identified as a potential new drug target for neurodegenerative diseases.

FOXP4-AS1 has also been implicated in the development and progression of autoimmune disorders. autoimmune disorders are a group of disorders that are characterized by the immune system attacking the body's own tissues. These disorders include rheumatoid arthritis, lupus, and multiple sclerosis.

The role ofFOXP4-AS1 in autoimmune disorders is not well understood, but it is thought to play a negative role.FOXP4-AS1 has been shown to promote the growth and survival of autoimmune disease-associated cells, and it has also been shown to inhibit the production of anti-autoimmune disease drugs. As a result, targetingFOXP4-AS1 has been identified as a potential new drug target for autoimmune disorders.

In conclusion, FOXP4-AS1 is a gene that encodes a protein that has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, targetingFOXP4-AS1 has been identified as a potential new drug target for these diseases. Further research is needed to fully understand the role ofFOXP4-AS1 in disease and to develop safe and effective drugs that target it.

Protein Name: FOXP4 Antisense RNA 1

The "FOXP4-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FOXP4-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets